CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.

OBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a...

Full description

Bibliographic Details
Main Authors: Qiliu Peng, Xianjun Lao, Weizhong Tang, Zhiping Chen, Ruolin Li, Jian Wang, Yan Deng, Taijie Li, Xue Qin, Shan Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3912176?pdf=render
id doaj-c56630fa16c5470a912769375532635a
record_format Article
spelling doaj-c56630fa16c5470a912769375532635a2020-11-25T01:22:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8792510.1371/journal.pone.0087925CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.Qiliu PengXianjun LaoWeizhong TangZhiping ChenRuolin LiJian WangYan DengTaijie LiXue QinShan LiOBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association. METHODS: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). RESULTS: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 -652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.821-0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95%CI 0.833-0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95%CI 0.761-0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95%CI 0.749-0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.813-0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95%CI 0.827-0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected. CONCLUSIONS: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association.http://europepmc.org/articles/PMC3912176?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Qiliu Peng
Xianjun Lao
Weizhong Tang
Zhiping Chen
Ruolin Li
Jian Wang
Yan Deng
Taijie Li
Xue Qin
Shan Li
spellingShingle Qiliu Peng
Xianjun Lao
Weizhong Tang
Zhiping Chen
Ruolin Li
Jian Wang
Yan Deng
Taijie Li
Xue Qin
Shan Li
CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
PLoS ONE
author_facet Qiliu Peng
Xianjun Lao
Weizhong Tang
Zhiping Chen
Ruolin Li
Jian Wang
Yan Deng
Taijie Li
Xue Qin
Shan Li
author_sort Qiliu Peng
title CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
title_short CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
title_full CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
title_fullStr CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
title_full_unstemmed CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
title_sort casp8 -652 6n del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description OBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association. METHODS: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). RESULTS: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 -652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.821-0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95%CI 0.833-0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95%CI 0.761-0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95%CI 0.749-0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.813-0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95%CI 0.827-0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected. CONCLUSIONS: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association.
url http://europepmc.org/articles/PMC3912176?pdf=render
work_keys_str_mv AT qiliupeng casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT xianjunlao casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT weizhongtang casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT zhipingchen casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT ruolinli casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT jianwang casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT yandeng casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT taijieli casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT xueqin casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT shanli casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
_version_ 1725125703276429312